Search
Search Results
-
Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management
Chronic urticaria (CU) is a common skin condition characterized by the recurrence of wheals, with or without angioedema, which lasts for at least...
-
-
Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018)
The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: Allergy, Paediatric Allergy and Immunology as well as...
-
Surgery for prolactinomas: a better choice?
PurposeRenewed interest in transsphenoidal surgery (TSS) as a therapeutic option for prolactinomas has emerged.
MethodsBased on contemporary...
-
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks
IntroductionFor prophylaxis of hereditary angioedema (HAE) attacks, replacement therapy with human C1-inhibitor (C1-INH) treatment is approved and...
-
Lanadelumab: First Global Approval
Shire is develo** lanadelumab (Takhzyro™) for the prevention of hereditary angioedema (HAE) attacks. Lanadelumab is a fully human monoclonal...
-
-
-
Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
BackgroundReal-world data on usage and associated outcomes with hereditary angioedema (HAE)-specific medications introduced to the United States (US)...
-
Urticaria and angioedema
Urticaria (hives) is a common disorder that often presents with angioedema (swelling that occurs beneath the skin). It is generally classified as...